Today’s Research Reports on Trending Tickers: OPKO Health and Ligand Pharmaceuticals
U.S. markets closed up on Wednesday, as investors appear to shrug off fears of increasing interest rate and bond yields. The Dow Jones Industrial Average gained 0.25 percent to close at 24,768.93, while the S&P 500 Index increased 0.41 percent to close at 2,722.46. The Nasdaq Composite Index climbed 0.63 percent to close at 7,398.30.
“For the 10-year, 3% isn’t a magical number that will pull investors out of stocks. With inflation and interest rates being where they are, we think stock valuations are about right. Equities certainly aren’t cheap, but valuations aren’t a big concern right now,” said Anthony Saglimbene, global market strategist at Ameriprise.
RDI Initiates Coverage on:
OPKO Health, Inc.
Ligand Pharmaceuticals Incorporated
OPKO Health’s stock jumped 5.72% Wednesday, to close the day at $4.99. The stock recorded a trading volume of 7,296,749 shares, which was above its three months average volume of 4,902,516 shares. In the last year, OPKO Health’s shares have traded in a range of 2.66 – 7.25. The share price has gained 87.59% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $3.36 is below its 200-day moving average of $4.27. Shares of OPKO Health have gained roughly 65.23 percent in the past month and are up 1.84 percent year-to-date.
Access RDI’s OPKO Health, Inc. Research Report at:
On Wednesday, shares of Ligand Pharmaceuticals recorded a trading volume of 590,205 shares, which was above the three months average volume of 322,462 shares. The stock ended the day 4.22% higher at $193.19. The share price has fallen 0.63% from its 52 week high with a 52 week trading range of 107.65 – 194.42. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $164.27 is above its 200-day moving average of $153.31. Shares of the company are trading at a Price to Earnings ratio of 364.51. Shares of Ligand Pharmaceuticals have gained roughly 15.23 percent in the past month and are up 41.09 percent year-to-date.
Access RDI’s Ligand Pharmaceuticals Incorporated Research Report at:
Our Actionable Research on OPKO Health, Inc. (NASDAQ:OPK) and Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.